FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey

NCT00683891 · clinicaltrials.gov ↗

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Weight Gain
Sialorrhea

Interventions

DRUG: FazaClo (clozapine, USP) ODT

Sponsor

Azur Pharma, Inc